Drug Shortage Report for CUPRIMINE
Report ID | 166020 |
Drug Identification Number | 00016055 |
Brand name | CUPRIMINE |
Common or Proper name | CUPRIMINE |
Company Name | BAUSCH HEALTH, CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | PENICILLAMINE |
Strength(s) | 250MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | N/A |
ATC code | M01CC |
ATC description | SPECIFIC ANTIRHEUMATIC AGENTS |
Reason for shortage | Shortage of an inactive ingredient or component. |
Anticipated start date | |
Actual start date | 2022-07-29 |
Estimated end date | 2022-09-09 |
Actual end date | 2022-08-31 |
Shortage status | Resolved |
Updated date | 2022-09-01 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2022-09-01 | French | Compare |
v6 | 2022-09-01 | English | Compare |
v5 | 2022-08-11 | French | Compare |
v3 | 2022-08-11 | English | Compare |
v4 | 2022-08-11 | English | Compare |
v2 | 2022-08-03 | French | Compare |
v1 | 2022-08-03 | English | Compare |
Showing 1 to 7 of 7